ReviewJournal of food and drug analysis2019
The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond.
Lin-Chau ChangPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it